全球药物再利用市场研究报告 - 产业分析、规模、份额、成长、趋势及预测（2025 年至 2033 年）

全球药物再利用市场预计将大幅成长，到 2033 年将达到 550 亿美元，高于 2024 年的 355.1 亿美元。预计 2025 年至 2033 年期间该市场的年复合成长率(CAGR) 为 4.98%。

全球药物再利用市场有望迎来显着成长，这得益于加速药物开发、降低成本以及满足未满足的医疗需求。药物再利用能够利用已知的安全性，为现有药物发现新的治疗用途。未来的发展将侧重于人工智慧驱动的药物发现、巨量资料分析以及与基因组和蛋白质组资料的整合。

此外，慢性病和罕见疾病的日益普及也扩大了药物再利用的机会。监管框架正在不断发展，以简化审批流程。合作研究和公私合作伙伴关係正在加速创新。随着医药研发的转型，药物再利用市场将持续创新，提供更快速、更具成本效益、更安全的治疗方案。

目录

第一章：前言

• 报告描述
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法
  • 市场研究流程
  • 市场研究方法

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第三章：药物再利用－产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业趋势
• 波特五力分析
• 市场吸引力分析
  • 按疾病适应症分析市场吸引力
  • 依方法类型分析市场吸引力
  • 按最终用户进行的市场吸引力分析
  • 市场吸引力分析：按地区

第四章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料製造商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第五章：全球药物再利用市场分析：按疾病适应症

• 按疾病适应症概述
• 依疾病指征进行历史及预测资料分析
• 肿瘤学
• 中枢神经系统疾病
• 神经退化性疾病
• 其他（罕见疾病等）

第六章：全球药物再利用市场分析：依方法类型

• 依方法类型概述
• 依方法类型分析历史和预测数据
• 以疾病为中心的方法
• 以目标为中心的方法
• 以药物为中心的方法

第七章：全球药物再利用市场分析：按最终用户

• 最终用户概览
• 最终用户的历史和预测数据分析
• 医院和诊所
• 门诊手术中心
• 其他（研究机构等）

第 8 章：全球药物再利用市场分析：按地区

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美各细分市场销售分析
  • 北美各国销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲各细分市场销售分析
  • 欧洲各国销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区分部销售分析
  • 亚太地区国家销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲各细分市场销售分析
  • 拉丁美洲各国销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲分部销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东和非洲其他地区销售分析

第九章：药物再利用公司的竞争格局

• 药物再利用市场竞争
• 伙伴关係/合作/协议
• 併购
• 新产品发布
• 其他发展

第十章：公司简介

• 顶级公司市占率分析
• 市场集中度
• Algernon Pharmaceuticals
• 公司概况
• 公司收入
• 产品
• 最新动态
• Biovista Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Celentyx Ltd.
• 公司概况
• 公司收入
• 产品
• 最新动态
• ChemBio Discovery Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Chord Therapeutics SA
• 公司概况
• 公司收入
• 产品
• 最新动态
• Excelra
• 公司概况
• 公司收入
• 产品
• 最新动态
• Fios Genomics Ltd.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Lantern Pharma Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Novartis AG
• 公司概况
• 公司收入
• 产品
• 最新动态
• Paradigm Biopharmaceuticals Limited
• 公司概况
• 公司收入
• 产品
• 最新动态
• Predictive Oncology
• 公司概况
• 公司收入
• 产品
• 最新动态
• Segue Therapeutics LLC
• 公司概况
• 公司收入
• 产品
• 最新动态
• Teva Pharmaceutical Industries Ltd
• 公司概况
• 公司收入
• 产品
• 最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，或者在私人公司的情况下可能不涵盖

Global Drug Repurposing Market is poised to witness substantial growth, reaching a value of USD 55 Billion by the year 2033, up from USD 35.51 Billion attained in 2024. The market is anticipated to display a Compound Annual Growth Rate (CAGR) of 4.98% between 2025 and 2033.

The global drug repurposing market is poised for significant growth driven by the need to accelerate drug development, reduce costs, and address unmet medical needs. Drug repurposing identifies new therapeutic uses for existing drugs, leveraging known safety profiles. Future developments will focus on AI-driven drug discovery, big data analytics, and integration with genomic and proteomic data.

Moreover, increasing prevalence of chronic and rare diseases is expanding repurposing opportunities. Regulatory frameworks are evolving to facilitate approval pathways. Collaborative research and public-private partnerships are accelerating innovation. As pharmaceutical R&D transforms, the drug repurposing market will continue to innovate, delivering faster, cost-effective, and safer therapeutic solutions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the Drug Repurposing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Disease Indication

• Oncology
• CNS Diseases
• Neurodegenerative Diseases
• Others (Rare Disorders, etc.)

By Approach Type

• Disease-centric Approach
• Target-centric Approach
• Drug-centric Approach

By End User

• Hospitals & Clinics
• Ambulatory Surgery Centers
• Others (Research Institutes, etc.)
• List of Companies Profiled in the report
• Algernon Pharmaceuticals, Biovista Inc., Celentyx Ltd., ChemBio Discovery Inc., Chord Therapeutics SA, Excelra, Fios Genomics Ltd., Lantern Pharma Inc., Novartis AG, Paradigm Biopharmaceuticals Limited, Predictive Oncology, Segue Therapeutics LLC, Teva Pharmaceutical Industries Ltd.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. DRUG REPURPOSING - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Disease Indication
  • 3.7.2 Market Attractiveness Analysis By Approach Type
  • 3.7.3 Market Attractiveness Analysis By End User
  • 3.7.4 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL DRUG REPURPOSING MARKET ANALYSIS BY DISEASE INDICATION

• 5.1. Overview By Disease Indication
• 5.2. Historical and Forecast Data Analysis By Disease Indication
• 5.3. Oncology Historic and Forecast Sales By Regions
• 5.4. CNS Diseases Historic and Forecast Sales By Regions
• 5.5. Neurodegenerative Diseases Historic and Forecast Sales By Regions
• 5.6. Others (Rare Disorders, etc.) Historic and Forecast Sales By Regions

6. GLOBAL DRUG REPURPOSING MARKET ANALYSIS BY APPROACH TYPE

• 6.1. Overview By Approach Type
• 6.2. Historical and Forecast Data Analysis By Approach Type
• 6.3. Disease-centric Approach Historic and Forecast Sales By Regions
• 6.4. Target-centric Approach Historic and Forecast Sales By Regions
• 6.5. Drug-centric Approach Historic and Forecast Sales By Regions

7. GLOBAL DRUG REPURPOSING MARKET ANALYSIS BY END USER

• 7.1. Overview By End User
• 7.2. Historical and Forecast Data Analysis By End User
• 7.3. Hospitals & Clinics Historic and Forecast Sales By Regions
• 7.4. Ambulatory Surgery Centers Historic and Forecast Sales By Regions
• 7.5. Others (Research Institutes, etc.) Historic and Forecast Sales By Regions

8. GLOBAL DRUG REPURPOSING MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE DRUG REPURPOSING COMPANIES

• 9.1. Drug Repurposing Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF DRUG REPURPOSING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Algernon Pharmaceuticals
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Biovista Inc.
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Celentyx Ltd.
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. ChemBio Discovery Inc.
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Chord Therapeutics SA
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Excelra
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. Fios Genomics Ltd.
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. Lantern Pharma Inc.
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. Novartis AG
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. Paradigm Biopharmaceuticals Limited
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments
• 10.13. Predictive Oncology
  • 10.13.1 Company Overview
  • 10.13.2 Company Revenue
  • 10.13.3 Products
  • 10.13.4 Recent Developments
• 10.14. Segue Therapeutics LLC
  • 10.14.1 Company Overview
  • 10.14.2 Company Revenue
  • 10.14.3 Products
  • 10.14.4 Recent Developments
• 10.15. Teva Pharmaceutical Industries Ltd
  • 10.15.1 Company Overview
  • 10.15.2 Company Revenue
  • 10.15.3 Products
  • 10.15.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Disease Indication (USD MN)
• Oncology Market Sales By Geography (USD MN)
• CNS Diseases Market Sales By Geography (USD MN)
• Neurodegenerative Diseases Market Sales By Geography (USD MN)
• Others (Rare Disorders, etc.) Market Sales By Geography (USD MN)
• Analysis By Approach Type (USD MN)
• Disease-centric Approach Market Sales By Geography (USD MN)
• Target-centric Approach Market Sales By Geography (USD MN)
• Drug-centric Approach Market Sales By Geography (USD MN)
• Analysis By End User (USD MN)
• Hospitals & Clinics Market Sales By Geography (USD MN)
• Ambulatory Surgery Centers Market Sales By Geography (USD MN)
• Others (Research Institutes, etc.) Market Sales By Geography (USD MN)
• Global Drug Repurposing Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Drug Repurposing Report
• Market Research Process
• Market Research Methodology
• Global Drug Repurposing Market Size, By Regions (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Disease Indication
• Market Attractiveness Analysis By Approach Type
• Market Attractiveness Analysis By End User
• Market Attractiveness Analysis By Regions
• Value Chain Analysis
• Global Market Analysis By Disease Indication (USD MN)
• Oncology Market Sales By Geography (USD MN)
• CNS Diseases Market Sales By Geography (USD MN)
• Neurodegenerative Diseases Market Sales By Geography (USD MN)
• Others (Rare Disorders, etc.) Market Sales By Geography (USD MN)
• Global Market Analysis By Approach Type (USD MN)
• Disease-centric Approach Market Sales By Geography (USD MN)
• Target-centric Approach Market Sales By Geography (USD MN)
• Drug-centric Approach Market Sales By Geography (USD MN)
• Global Market Analysis By End User (USD MN)
• Hospitals & Clinics Market Sales By Geography (USD MN)
• Ambulatory Surgery Centers Market Sales By Geography (USD MN)
• Others (Research Institutes, etc.) Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.